Please note: we will be discontinuing the Global Markets Report after 28 February. Australian shares are set to open lower, ...

The Chart of the Week looks at Morningstar's stock valuations for the Australian market and how it compares to the past.

After a stellar run for banks, investors are wondering whether they can continue their outperformance or if a rotation into miners is imminent. There’s a good case that a switch is coming, and it may ...

The final quarter of 2024 presented a mixed bag for the New Zealand economy. While some indicators pointed towards a ...

LaMonica: And LISTO for those who do not know is a mechanism that is designed to offset tax and superannuation contributions for low income earners. This limit has not been updated to align with ...

Sharesight is a portfolio tracker that is integrated into Morningstar Investor. Their data shows the top 20 trades by ...

Gone are the days of the early 2000’s ‘Baby Bonus’, popularised by then-treasurer Peter Costello, in an attempt to curb the dwindling number of young Aussies having children. It is now 2025 and we are ...

A new year of investing insights.

I had a think about questions that continue to come up from investors - either from our articles or the podcast. This was my ...

Bias and emotion can cause otherwise rational people to make errors in judgment. To maximise your chances of success, it is vital to know thyself.

Welcome to the second edition of Megatrend Investing 2025 and beyond, where I discuss themes for the future and explore which ...

ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near ...